Efficacy of Liv-52 Against Drugs that Cause Liver Damage
Animals treated with the combination of INH, rifampicin and pyrazinamide showed a significant increase in liver peroxide contents, and a significant decrease on SOD, CAT, GPX and GST activities. Also the glutathione level was significantly reduced. Treatment with Liv.52 (500mg/kg, p.o.) significantly modified the hepatotoxic effect of the antitubercular drugs. As shown in Table 2, Liv.52 afforded protection against lipid peroxidation, the above-mentioned parameters being almost restored to normal values. To read more about this study, visit Hepatoprotective effect of Liv.52 on antitubercular drug-induced hepatotoxicity in rats - Vijaya Padma, V, Suja, V. and Shyamala Devi, C.S., Fitoterapia (1998): (LXIX), 6, 520.
Liv.52 improves the function of hepatocytes and promotes the regeneration of the necrosed cells, thereby improving the protein synthesis. It diminishes the activity of serum transaminases and arrests the cell necrosis and inflammation. It is observed histologically in Group I cases the persistence of necrotic changes, granulomata formation progressing to stellate fibrosis, which is not seen in Group II cases. Therefore it can be said that Liv.52 restores normal liver functions earlier and in shorter duration, improves appetite, gives sense of well being, is anti-inflammatory and effectively contributes to healthy repair and regeneration of liver cells which proves its hepato-protective role.To read more about this study, visit Hepatoprotective role of indigenous drug Liv.52 in lepromatous leprosy - Pranesh Nigam and Mukhija, R.D., Hansenlogia Internationalis, Brazil (1982): (7), 1, 36.
All research studies and clinical trials on efficacy of Liv-52 against medications that cause liver damage
- Effect of spirulina and Liv.52 on cadmium Indiuced toxicity in albino rats (pdf)
K Jeyaprakash & P Chinnaswamy Department of Biochemistry, Dr.N.G.P.Arts & Science College, Kovai Medical Center Research & Educational Trust, Coimbatore 641 014, India.
- Effect of hepatoprotective agent Liv.52 on nutrition parameters in hemodialysis patients (pdf)
Gordana Perunicic-Pekovic, Ljiljana Komadina, Steva Pljesa,
Zorica Rasic-Milutinovic, Rodoljub Markovic, Department of Nephrology, University Hospital,
Zemun-Belgrade and Natasa Milic, Institute of Statistics, Belgrade Medical School, Zemun-Belgrade,
Medicine Update - Anniversary Issue, 2003, pp. 52-56.
- Protective
effect of Liv.52 on Na+-K+-ATPase activity in paracetamol-induced
hepatotoxicity (pdf)
Kala Suhas Kulkarni*, Md. Rafiq, Gopumadhavan,
S., Venkataranganna, M.V., Madhumathi, B.G. and Mitra, S.K. R&D
Center, The Himalaya Drug Company, Makali, Bangalore, India, Medicine
Update (2002): (10), 5, 53-56.
- Therapeutic
efficacy of Liv.52 in paracetamol induced hepatopathy in rabbits (pdf)
Anup Bhaumik and Sharma, M.C. Division
of Experimental Medicine and Surgery, Indian Veterinary Research
Institute, Izatnagar, Uttar Pradesh, India, Indian Journal Veterinary
Research (2002): (11), 1, 8-17.
- Hepatoprotective
effect of Liv.52 on antitubercular drug-induced hepatotoxicity
in rats (pdf)
Vijaya Padma, V, Suja, V. and Shyamala
Devi, C.S. Department of Biochemistry, University of Madras, Guindy
Campus, Madras, India. and Prema, Head-Department of Biochemistry,
Tuberculosis Research Centre, Chetpet, Chennai, India, Fitoterapia
(1998): (LXIX), 6, 520.
- Effect
of phytotherapy on prevention and elimination of hepatotoxic reactions
in patients with pulmonary tuberculosis and carriers of hepatitis
B virus markers (pdf)
Galitsky, L.A., Barnaulov, O.D., Zaretskii,
B.V., Malkov, M.I., Konenkov, S.I., Gol’m, N.P., Tomakov,
V.S., Ogarkov, P.I. and Batskov, S.S. Military Academy of Medicine,
Human Brain Institute of the Russian Academy of Sciences, Saint-Petersburg,
Russia, Problems of Tuberculosis,
(1997): 4, 35.
- Hepatoprotective
role of Liv.52 against hepatitis-induced by antitubercular drugs (pdf)
Ashish Khare, Department of Medicine,
Institute of Medical Sciences, Banaras Hindu University, Varanasi,
Uttar Pradesh, Probe (1992): (XXXI), 3, 260.
- Efficacy
of Liv.52 and Geriforte as adjuvant in various carcinomas (pdf)
Durgesh Kumar Acharya, Regional Centre
for Cancer Research and Treatment, Cuttack, Orissa, Probe (1986):
(XXV), 3, 249.
- Role
of Liv.52 in cyclophosphamide-induced alopecia (pdf)
Harbans Lal Kapoor, Seam, R.K. and Sanjiv
Sharma, Department of Radiation Therapy and Oncology, Indira Gandhi
Medical College, Simla, Himachal Pradesh, Probe (1986): (XXV),
4, 344.
- Hepatoprotective
role of indigenous drug Liv.52 in lepromatous leprosy (pdf)
Pranesh Nigam and Mukhija, R.D., B.R.D.
Medical College, Gorakhpur, Dayal, S.G., Government Medical College,
Jammu-Tawi, Goyal, B.M. and Joshi, L.D., M.L.B. Medical College,
Jhansi, Madhya Pradesh, Hansenlogia
Internationalis, Brazil (1982): 7, 1, 36.
- Experience
with Liv.52 as an adjuvant to anti-tubercular treatment (pdf)
Vinod Kumar Gupta, The Sincere Dispensary
and Nursing Home, Rori Bazar, Sirsa, Haryana, Capsule (1980):
6, 122.
- Effect
of Liv.52 on hepatic enzymes (pdf)
Alok Saxena and Garg, N.K., Division of
Biochemistry, Central Drug Research Institute, Lucknow, Uttar
Pradesh, Indian Journal of Experimental Biology (1979): 7, 662.
- The
effect of Liv.52 on liver functions of tubercular patients receiving
second line anti-tubercular drugs (pdf)
Brij Kishore, Hazra, D.U., Sachan, A.S.,
Agrawal, B.M., Bharadwaj, Ashok Kumar and Mehrotra, M.M.N., Postgraduate
Department of Medicine, S.N. Medical College, Agra, Uttar Pradesh,
Probe (1978): (XVII), 2, 125.
- Some
observations with Liv.52 therapy in cases of malignancy (pdf)
Harish Kulkarni, R.S.T. Cancer Centre,
Nagpur, Maharashtra, Probe (1978): (XVII), 3, 233.
- Effect
of an indigenous (herbal) drug Liv.52 on the hepatic damage caused
by oral contraceptives – A biochemical (enzymatic) approach (pdf)
Khuteta, K.P., Upgraded Department of
Physiology and Biochemistry, S.M.S. Medical College, Jaipur, Rajasthan,
Probe (1978): (XVII), 2, 115.
- Leprous
hepatitis: Clinico-pathological study and therapeutic efficacy
of Liv.52 (pdf)
Pranesh Nigam, Dayal, S.G., Goyal, B.M.,
Nimkhedakar, K., Joshi, L.D. and Samuel K.C., M.L.B. Medical College,
Jhansi, Uttar Pradesh, Leprosy in India (1978): (50), 2, 185.
- Tissue
culture and electron microscopic study on regeneration of liver
with Liv.52 (pdf)
Prasad, G.C., Department of Shalya and
Surgical Research Laboratory, Institute of Medical Science, Banaras
Hindu University, Varanasi, Uttar Pradesh,Capsule (1978): 6, 122.
- Liv.52-induced
modification of barbiturate hypnosis in albino rats (pdf)
Joglekar, G.V., Saraf, A.P., Moholkar,
A.L. and Shirole, M.V. (Miss.), Department of Pharmacology, B.J.
Medical College, Pune, Maharashtra, Maharashtra Medical Journal
(1977): (XXIV), 2, 67.
- Paracetamol-induced
hepatotoxicity and the protective effect of Liv.52 (pdf)
Mujumdar, S.M. and Kulkarni, R.D., Department
of Pharmacology, B.J. Medical College, Pune, Maharashtra, The
Indian Practitioner (1977): (XXX), November, 479.
- Anorexia
in osteoarticular tuberculosis (pdf)
Dabral, P.K., Srivastava, M.K. and Madhu
Dabral (Mrs.), M.L.B. Medical College, Jhansi, Madhya Pradesh,
Probe (1976): (XV), 3, 199.
- Electron
microscopic study on the effect of Liv.52 on carbon tetrachloride
treated liver (pdf)
Prasad, G.C., Department Shalya and Surgical
Research Laboratory, Institute of Medical Sciences, Banaras Hindu
University, Varanasi, Uttar Pradesh, Journal of Research in Indian
Medicine, Yoga and Homeopathy (1976): 4, 38.
- Role
of Liv.52 in hepatomegaly associated with childhood tuberculosis
(A clinico-histopathological study) (pdf)
Kumar, P. and Shishupal Ram, Department
of Paediatrics, Patna Medical College Hospital, Patna, Bihar,
The Indian Practitioner (1975): 10, 535.
- Place
of Liv.52 as an adjuvant to chemotherapy of malignant diseases (pdf)
Munuswamy, G. and Gajraj, A., Barnard
Institute of Radiology and Cancer, Government General Hospital
and Madras Medical College, Madras, Tamil Nadu, Probe (1975):
(XV), 1, 1.
- Effect
of Liv.52 on the liver in vitro (pdf)
Prasad, G.C., Department of Shalya and
Surgical Research Laboratory, Institute of Medical Sciences, Banaras
Hindu University, Varanasi, Uttar Pradesh, Journal of Research
in Indian Medicine (1975): 4, 15.
- Effect
of Liv.52 on regeneration of liver cells in tissue culture –
A preliminary report (pdf)
Prasad, G.C., Department of Shalya Shalakya
and Surgical Research Laboratory, Institute of Medical Sciences,
Banaras Hindu University, Varanasi, Uttar Pradesh, Journal of
Research in Indian Medicine (1974): (9), 2, 60.
- Liv.52
as adjuvant therapy with hepatotoxic and cytotoxic drugs (pdf)
Vaidya, M.D., Katra Hospital, Mandla,
Madhya Pradesh, Probe (1974): (XIII), 2, 73.
- Liv.52
improves thioacetazone tolerance (pdf)
Major Jayaram, C.N., T.B. Sanatorium,
Austinpatti, Madurai, Tamil Nadu, Probe (1969): (VIII), 4, 160.
|
Home
